Segal Institute For Clinical is categorized under Research Institute in Miami, FL and active since 1999.
Segal Institute For Clinical was established in 1999, and today employs 1 to 4, earning Unknown per year. This is a Research Institute business, which does work in the B2B market, and is classified as a Research Institute, under code number 8139100 by the NAICS.
If you are seeking more information, feel free to contact Scott Segal, President at the company’s single location by writing to 1065 Ne 125th St # 417, Miami, Florida FL 33161 or by phoning (305) 891-0050. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Segal Institute For Clinical |
| Contact Person: | Scott Segal, President |
| Address: | 1065 Ne 125th St # 417, Miami, Florida 33161 |
| Phone Number: | (305) 891-0050 |
| Website Address: | segalinstitute.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research Institute |
| SIC Code: | 8733 |
| NAICS Code: | 8139100 |
| Share This Business: |
Segal Institute For Clinical was started in 1999 to provide professional Research Institute under the SIC code 8733 and NAICS code 8139100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Scott Segal, President for inquiries that concern Segal Institute For Clinical by calling the company number (305) 891-0050, as your correspondence is most welcome. Additionally, the physical location of the single location of Segal Institute For Clinical can be found at the coordinates 25.890761,-80.175963 as well as the street address 1065 Ne 125th St # 417 in Miami, Florida 33161.
For its online presence, you may visit Segal Institute For Clinical’s website at segalinstitute.com and engage with its social media outlets through on Twitter and on Facebook.